Answers are grounded in this paper and cite their sources.
PURPOSE: Subclinical infection of breast implants has been suggested to trigger capsular contracture. This study aimed to investigate the breast implant microbiome and to find potential microbial causes of capsular contracture. METHODS: We included 141 implants from 72 healthy patients from a larger biobank to create groups with or without capsular contracture that were matched by time of implantation, implant brand and surface texture. Bacterial DNA was isolated from the entire implant surface using sonication and analyzed with amplicon sequencing of the hypervariable V3-V4 region of the bacterial 16S rRNA gene. RESULTS: We included 38 patients who acted as their own control by contributing with one breast with capsular contracture (Baker III/IV) and a contralateral healthy breast (Baker I). Sixteen patients were Baker I bilaterally, 15 patients were Baker III/IV bilaterally and three patients contributed with one breast with Baker III/IV. We identified a rich network of bacteria in all samples with 879 unique genera. The core implant microbiome consisted of Staphylococcus, Pelomonas and Micrococcus genera. The relative abundance of Staphylococcus was significantly higher on implants with capsular contracture than the control group (p=0.004). CONCLUSION: We identified a unique implant microbiome in healthy patients. Implants with capsular contracture had a higher relative abundance of the Staphylococcus genus compared with Baker I implants supporting the hypothesis that traits of the implant microbiome may cause capsular contracture.
No takes yet. Share an insight, caveat, or question.
Weltz et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: